Axsome Therapeutics (AXSM) PT Raised to $256 at Wells Fargo

August 11, 2026 6:54 AM

Wells Fargo analyst Benjamin Burnett raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $256.00 (from $255.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found